^Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD (March 1998). "Discovery of nonsteroidal androgens". Biochemical and Biophysical Research Communications. 244 (1): 1–4.
doi:
10.1006/bbrc.1998.8209.
PMID9514878.
^
abcdefYin D, Xu H, He Y, Kirkovsky LI, Miller DD, Dalton JT (March 2003). "Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor". The Journal of Pharmacology and Experimental Therapeutics. 304 (3): 1323–33.
doi:
10.1124/jpet.102.040832.
PMID12604713.
S2CID6816508.
^
abcPerera MA, Yin D, Wu D, Chan KK, Miller DD, Dalton J (October 2006). "In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs". Drug Metabolism and Disposition. 34 (10): 1713–21.
doi:
10.1124/dmd.106.009985.
PMID16815963.
S2CID14708913.
^Kim J, Wu D, Hwang DJ, Miller DD, Dalton JT (October 2005). "The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators". The Journal of Pharmacology and Experimental Therapeutics. 315 (1): 230–9.
doi:
10.1124/jpet.105.088344.
PMID15987833.
S2CID30799845.